Effect of the Antimicrobial Peptide GL13K on Dental Implant Surfaces: A Review

The GL13K peptide is beneficial for dental implants, improving biocompatibility and modulating osteoclast activity. This article focuses on GL13K-peptide-modified titanium surfaces, analyzing their influence on dental implants. The success of a dental implant is dependent on osseointegration, which is a combined function of osteoblasts and osteoclasts. While most studies focus on osteogenic differentiation, the activity of osteoclasts is rarely studied. The GL13K peptide, which is antimicrobial, can be covalently grafted onto titanium surfaces by a silanization method, which is advantageous because it forms biocompatible surfaces that also partially suppress osteoclastogenesis. Research has shown that titanium surfaces modified with GL13K peptides (GL13K-Ti) exhibit reduced expression of osteoclastogenic genes and proteins and inhibited actin ring formation. Further studies have demonstrated that GL13K-Ti alters osteoclast secretion of pro-inflammatory cytokines, causing osteoclasts to be less active by an epigenetic mechanism, namely, changing the methylation of histone H3K27 on the NFATc1 promoter region during RANKL-driven osteoclast formation. These results imply that the modification of dental implant surfaces with the GL13K peptide may have two applications, namely, improving biocompatibility and regulating osteoclast activity through epigenetic mechanisms. This method offers a novel way to enhance dental implant outcomes, especially in difficult clinical situations. The coating process should be optimized, long-term stability and efficacy should be examined, and possible synergistic effects with other surface modifications or bioactive molecules should be investigated in future studies.